ClinicalTrials.Veeva

Menu

Loss of Cervical Lordosis in Fibromyalgia Syndrome

A

Ankara City Hospital

Status

Completed

Conditions

Fibromyalgia, Cervical Lordosis

Treatments

Other: Visual Analog Scale (VAS), QOL (36-Item Short Form Survey (SF-36)), and Neck Disability Index (NDI) were used to assess pain, overall quality of life, functional disability respectively.

Study type

Observational

Funder types

Other

Identifiers

NCT06408675
B.10.1.TKH.4.34.H.GP.0.01/146

Details and patient eligibility

About

Purpose: The causes of chronic and widespread pain in fibromyalgia (FMS) have not been eluciated yet. Previous reports determined that posture control changed, muscle strength decreased, body posture misaligned (maladaptive posture), and functional capacity decreased in FMS patients. The aim of this study was to investigate the relationship between loss of cervical lordosis, pain, quality of life (QOL) and neck disability in patients with FMS.

Methods: A total of 107 FMS (88 females and 20 males; range of age:18-65) were included to the study. Patients were divided into two groups according to the angle of cervical lordosis measured by the Cobb method, group 1 with a Cobb angle of ≤10°, and group 2 with an angle greater than >10°. Visual Analog Scale (VAS), QOL (36-Item Short Form Survey (SF-36)), and Neck Disability Index (NDI) were used to assess pain, overall quality of life, functional disability respectively.

Enrollment

107 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age range between 18 and 65

-Patients diagnosed with fibromyalgia according to the American College of Rheumatology 1990 criteria

Exclusion criteria

Patients diagnosed with known systemic (e.g., inflammatory rheumatic diseases, diabetes mellitus and systemic arterial hypertension), metabolic or endocrine diseasesas well as tumoral, neurologic or infectious diseases,

  • Patients with a history of trauma and surgery affecting the neck area,
  • Patients who received trigger point injection therapy for neck pain within the last 6 months,
  • Patients with cervical disc herniation or myelopathy, spondylolisthesis, spondylolysis, cervicothoracic kyphoscoliosis,
  • Patients who had been receiving therapy for any psychiatric diagnosis for the last 3 months and antidepressant drug use,
  • Patients with history of neuropathic diseases,
  • Patients with a condition affecting neck muscles, such as dystonia,
  • Inflammatory muscle disease and myopathy
  • Pregnant patients were not included to the study

Trial design

107 participants in 2 patient groups

group 1 with a Cobb angle of ≤10°
Description:
cervical lordosis cobb angele ≤10°
Treatment:
Other: Visual Analog Scale (VAS), QOL (36-Item Short Form Survey (SF-36)), and Neck Disability Index (NDI) were used to assess pain, overall quality of life, functional disability respectively.
group 2 with an angle greater than >10°
Description:
cervical lordosis cobb angele \>10°
Treatment:
Other: Visual Analog Scale (VAS), QOL (36-Item Short Form Survey (SF-36)), and Neck Disability Index (NDI) were used to assess pain, overall quality of life, functional disability respectively.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems